ARID1B and non-small cell lung carcinoma: Taken together, our findings consistently demonstrate that high expression of ARID1B in NSCLC is associated with immune suppression, as evidenced by lower immune scores, reduced immune cell infiltration, and negative correlations with multiple immune-related cell types and functions.